Assessment of factor V leiden, prothrombin gene mutation and methylenetetrahydrofolate reductase activity in pediatric patients with thalassemia - Egyptian Knowledge Bank - troweb

42595

Assessment of factor V leiden, prothrombin gene mutation and methylenetetrahydrofolate reductase activity in pediatric patients with thalassemia

Thesis

Last updated: 06 Feb 2023

Overview Similar Items

Thesis

Detection of factor V leidenmutation in children with portal vein thrombosis

Thesis

Assessment of bleeding tendency & platelet activation in thalassemic children

Thesis

Association of factor V leiden and prothrombin gene mutations with thrombotic risk in patients with sickle cell anemia

Thesis

Study of methylenetetraydrofolate reductase gene mutation as a risk factor for deep venous thrombosis

Thesis

Methylenetetrahydrofolate reductase gene mutation as a predisposing factor for primary deep venous thrombosis

Thesis

Factor II G 20210 a mutation in idiopathic portal vein thrombosis in children

Thesis

Study of MTHFR gene mutation in normal mothers and

Thesis

Studyy of some of the ameliorating factors in homozygous Beta thalassemia

Thesis

Retrospective epidemiological study among thalassemia intermedia pediatric patients

Thesis

Thrombotic tendency in renal diseases in pediatrics